Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2026-03-01 @ 12:17 AM
Study NCT ID:
NCT01868061
Status:
COMPLETED
Last Update Posted:
2017-05-19
First Post:
2013-05-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Asthma | View |
Keywords: